Страна: Израел
Език: английски
Източник: Ministry of Health
OCTOCOG ALFA (ANTIHEMOPHILIC FACTOR RECOMBINANT)
TAKEDA ISRAEL LTD
B02BD02
POWDER FOR SOLUTION FOR INJECTION
OCTOCOG ALFA (ANTIHEMOPHILIC FACTOR RECOMBINANT) 500 IU/VIAL
I.V
Required
BAXTER AG, AUSTRIA
COAGULATION FACTOR VIII
COAGULATION FACTOR VIII
Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).
2018-09-30
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT ADVATE 250 IU powder and solvent for solution for injection. ADVATE 500 IU powder and solvent for solution for injection. ADVATE 1000 IU powder and solvent for solution for injection. ADVATE 1500 IU powder and solvent for solution for injection. ADVATE 2000 IU powder and solvent for solution for injection. ADVATE 3000 IU powder and solvent for solution for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION _ _ _ADVATE 250 IU powder and solvent for solution for injection. _ Each vial contains nominally 250 IU human coagulation factor VIII (rDNA), octocog alfa. ADVATE contains approximately 50 IU per ml of human coagulation factor VIII (rDNA), octocog alfa after reconstitution. _ADVATE 500 IU powder and solvent for solution for injection. _ Each vial contains nominally 500 IU human coagulation factor VIII (rDNA), octocog alfa. ADVATE contains approximately 100 IU per ml of human coagulation factor VIII (rDNA), octocog alfa after reconstitution. _ADVATE 1000 IU powder and solvent for solution for injection. _ Each vial contains nominally 1000 IU human coagulation factor VIII (rDNA), octocog alfa. ADVATE contains approximately 200 IU per ml of human coagulation factor VIII (rDNA), octocog alfa after reconstitution. _ADVATE 1500 IU powder and solvent for solution for injection. _ Each vial contains nominally 1500 IU human coagulation factor VIII (rDNA), octocog alfa. ADVATE contains approximately 300 IU per ml of human coagulation factor VIII (rDNA), octocog alfa after reconstitution. _ADVATE 2000 IU powder and solvent for solution for injection. _ Each vial contains nominally 2000 IU human coagulation factor VIII (rDNA), octocog alfa. ADVATE contains approximately 400 IU per ml of human coagulation factor VIII (rDNA), octocog alfa after reconstitution. _ADVATE 3000 IU powder and solvent for solution for injection. _ Each vial contains nominally 3000 IU human coagulation factor VIII (rDNA), octocog alfa. ADVATE contains approximately 600 IU per ml Прочетете целия документ